Læknablaðið - 15.03.2005, Page 49

ASPIRIVA(TIOTROPIUM)
Meira loft í lungun
SPIRIVA"
er grunnurinn í
meðhöndlun á LLT1i2>
A Minnkar mæði við áreynslu31
A Eykur þoi eftir áreynslu31
A Fækkar versnunum og innlögnum
vegna þeirra41
A Eykur lífsgæði sjúklings5’
^eimiidir: I) Medicinsk Kompendium 2004; bls 1331.2) Tashkin et al. Review.The Role of Long-Acting Bronchodilators in the Management of Stable COPD. CHEST 2004;125:249-259. 3) O'Donnell et al. Effects of tiotropium on lung hyperinflation,
^yspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832-840. 4) Casaburi et al.A long-term evaluation of once daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19:217-224. 5) Vincken et al. Improved health
°utcomes in patients with COPD during I years treatment with tiotropium. Eur Respir J 2002;19:209-216.

Umboðsaðili: PharmaNor hf.
Hörgatúni 2,210 Garðabær
Sími: 53S 7000. www.Dfizer.is
Sérlyfjatexti á bls. 314
'jjiA Boehringer
illlllv Ingelheim